Inhibition of Angiopoietin-2 in LuCaP 23.1 Prostate Cancer Tumors Decreases Tumor Growth and Viability

BACKGROUND: Angiopoietin-2 is expressed in prostate cancer (PCa) bone, liver, and lymph node metastases, whereas, its competitor angiopoietin-1 has limited expression in these tissues. Therefore, we hypothesized that the inhibition of angiopoietin-2 activity in PCa metastasis (removed) will impede a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Morrissey, Colm, Dowell, Alex, Koreckij, Theodore D., Nguyen, Holly, Lakely, Bryce, Fanslow, William C., True, Lawrence D., Corey, Eva, Vessella, Robert L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3104406/
https://ncbi.nlm.nih.gov/pubmed/20583134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21216
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller